Kim M. Keeling

3.6k total citations
41 papers, 2.6k citations indexed

About

Kim M. Keeling is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Kim M. Keeling has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Physiology. Recurrent topics in Kim M. Keeling's work include RNA and protein synthesis mechanisms (13 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Cystic Fibrosis Research Advances (9 papers). Kim M. Keeling is often cited by papers focused on RNA and protein synthesis mechanisms (13 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Cystic Fibrosis Research Advances (9 papers). Kim M. Keeling collaborates with scholars based in United States, Israel and United Kingdom. Kim M. Keeling's co-authors include David M. Bedwell, Marina Manuvakhova, Joseph X. Ho, Daniel C. Carter, Ming Du, Brian L. Chang, Dan Wang, Steven M. Rowe, Venkateshwar Mutyam and Xiaoli Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kim M. Keeling

40 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim M. Keeling United States 25 2.0k 430 305 221 207 41 2.6k
Jiahai Shi Hong Kong 27 2.0k 1.0× 135 0.3× 197 0.6× 259 1.2× 145 0.7× 78 2.9k
Margaret McLaughlin United States 27 2.0k 1.0× 438 1.0× 334 1.1× 240 1.1× 304 1.5× 33 3.1k
Akihiko Tsuji Japan 28 1.5k 0.8× 151 0.4× 199 0.7× 445 2.0× 448 2.2× 127 2.7k
Laura E. Herring United States 26 1.6k 0.8× 263 0.6× 157 0.5× 211 1.0× 147 0.7× 100 2.9k
John L. Joyal United States 30 1.8k 0.9× 1.2k 2.9× 221 0.7× 181 0.8× 260 1.3× 54 3.8k
Chang‐Deng Hu United States 31 2.2k 1.1× 327 0.8× 172 0.6× 134 0.6× 494 2.4× 57 3.0k
Minh Lam United States 29 1.3k 0.7× 680 1.6× 162 0.5× 132 0.6× 236 1.1× 55 2.4k
Christopher M. Koth United States 23 2.2k 1.1× 97 0.2× 313 1.0× 81 0.4× 200 1.0× 36 2.7k
Alexis Traynor‐Kaplan United States 31 2.6k 1.3× 307 0.7× 180 0.6× 394 1.8× 1.2k 5.7× 58 3.9k
Hagit Dafni Israel 23 835 0.4× 115 0.3× 107 0.4× 141 0.6× 149 0.7× 35 2.1k

Countries citing papers authored by Kim M. Keeling

Since Specialization
Citations

This map shows the geographic impact of Kim M. Keeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim M. Keeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim M. Keeling more than expected).

Fields of papers citing papers by Kim M. Keeling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim M. Keeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim M. Keeling. The network helps show where Kim M. Keeling may publish in the future.

Co-authorship network of co-authors of Kim M. Keeling

This figure shows the co-authorship network connecting the top 25 collaborators of Kim M. Keeling. A scholar is included among the top collaborators of Kim M. Keeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim M. Keeling. Kim M. Keeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jianguo, Lianwu Fu, D. Woodrow Benson, et al.. (2025). Identity, functional consequences, and context effects of amino acids inserted during suppression of CFTR nonsense mutations. Journal of Cystic Fibrosis. 25(1). 106–117.
2.
Fu, Lianwu, et al.. (2024). Extended stop codon context predicts nonsense codon readthrough efficiency in human cells. Nature Communications. 15(1). 2486–2486. 14 indexed citations
3.
Chen, Jianguo, Lianwu Fu, Wei Wang, et al.. (2023). The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(6). L756–L770. 14 indexed citations
4.
5.
Sharma, Jyoti, Kim M. Keeling, & Steven M. Rowe. (2020). Pharmacological approaches for targeting cystic fibrosis nonsense mutations. European Journal of Medicinal Chemistry. 200. 112436–112436. 29 indexed citations
6.
Mutyam, Venkateshwar, Ming Du, Kim M. Keeling, et al.. (2016). Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations. American Journal of Respiratory and Critical Care Medicine. 194(9). 1092–1103. 63 indexed citations
7.
Roy, Bijoyita, Westley J. Friesen, John Leszyk, et al.. (2016). Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression. Proceedings of the National Academy of Sciences. 113(44). 12508–12513. 161 indexed citations
8.
Keeling, Kim M., et al.. (2012). Suppression of premature termination codons as a therapeutic approach. Critical Reviews in Biochemistry and Molecular Biology. 47(5). 444–463. 78 indexed citations
9.
Keeling, Kim M. & David M. Bedwell. (2011). Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdisciplinary Reviews - RNA. 2(6). 837–852. 71 indexed citations
10.
Du, Ming, Kim M. Keeling, Liming Fan, Xiaoli Liu, & David M. Bedwell. (2009). Poly-l-aspartic Acid Enhances and Prolongs Gentamicin-mediated Suppression of the CFTR-G542X Mutation in a Cystic Fibrosis Mouse Model. Journal of Biological Chemistry. 284(11). 6885–6892. 38 indexed citations
11.
Wang, Dan, Charu Shukla, Xiaoli Liu, et al.. (2009). Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation. Molecular Genetics and Metabolism. 99(1). 62–71. 46 indexed citations
12.
Fan-Minogue, Hua, Ming Du, Andrey V. Pisarev, et al.. (2008). Distinct eRF3 Requirements Suggest Alternate eRF1 Conformations Mediate Peptide Release during Eukaryotic Translation Termination. Molecular Cell. 30(5). 599–609. 49 indexed citations
13.
Du, Ming, Kim M. Keeling, Liming Fan, et al.. (2006). Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model. Journal of Molecular Medicine. 84(7). 573–582. 58 indexed citations
14.
Keeling, Kim M., et al.. (2006). Tpa1p Is Part of an mRNP Complex That Influences Translation Termination, mRNA Deadenylation, and mRNA Turnover in Saccharomyces cerevisiae. Molecular and Cellular Biology. 26(14). 5237–5248. 47 indexed citations
15.
Keeling, Kim M. & David M. Bedwell. (2005). Pharmacological Suppression of Premature Stop Mutations that Cause Genetic Diseases. 3(4). 259–269. 25 indexed citations
16.
Keeling, Kim M., et al.. (2004). Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae. RNA. 10(4). 691–703. 137 indexed citations
17.
Du, Ming, Kim M. Keeling, Albert Tousson, et al.. (2002). Aminoglycoside suppression of a premature stop mutation in a Cftr–/– mouse carrying a human CFTR-G542X transgene. Journal of Molecular Medicine. 80(9). 595–604. 143 indexed citations
18.
19.
Carter, Daniel C., et al.. (1994). Preliminary Crystallographic Studies of Four Crystal forms of Serum Albumin. European Journal of Biochemistry. 226(3). 1049–1052. 232 indexed citations
20.
Lim, Kap, Joseph X. Ho, Kim M. Keeling, et al.. (1994). Three‐Dimensional structure of schistosoma japonicum glutathione s‐transferase fused with a six‐amino acid conserved neutralizing epitope of gp41 from hiv. Protein Science. 3(12). 2233–2244. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiahai Shi Breakdown of academic impact, for papers by Margaret McLaughlin Breakdown of academic impact, for papers by Akihiko Tsuji Breakdown of academic impact, for papers by Laura E. Herring Breakdown of academic impact, for papers by John L. Joyal Breakdown of academic impact, for papers by Chang‐Deng Hu Breakdown of academic impact, for papers by Minh Lam Breakdown of academic impact, for papers by Christopher M. Koth Breakdown of academic impact, for papers by Alexis Traynor‐Kaplan Breakdown of academic impact, for papers by Hagit Dafni
Rankless by CCL
2026